Back
Mirati Therapeutics Stock Price Chart
Sponsored
10 POWERFUL Patterns...
Click here to download your copy now
Sell
13
MRTX
Mirati Therapeutics
Last Price:
39.40
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
20-cent Gold Stock Has Backing of Major Gold Producers
The time to get in is now BEFORE next drill results are released.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRTX is experiencing slight selling pressure.
Mirati Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.42 | Sell |
| 20-day SMA: | 42.95 | Sell |
| 50-day SMA: | 45.98 | Sell |
| 200-day SMA: | 62.05 | Sell |
| 8-day EMA: | 41.57 | Sell |
| 20-day EMA: | 43.04 | Sell |
| 50-day EMA: | 46.55 | Sell |
| 200-day EMA: | 63.6 | Sell |
Mirati Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.73 | Sell |
| Relative Strength Index (14 RSI): | 39.46 | Sell |
| Chaikin Money Flow: | -134301 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.06 - 46.7) | Sell |
| Bollinger Bands (100): | (38.55 - 69.69) | Sell |
Mirati Therapeutics Technical Analysis
| Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mirati Therapeutics Stock
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 40.72 while MRTX 8-day simple moving average is 41.42, which is a Sell signal.
- The stock price of MRTX is 40.72 while Mirati Therapeutics 20-day SMA is 42.95, which makes it a Sell.
- Mirati Therapeutics 50-day simple moving average is 45.98 while MRTX share price is 40.72, making it a Sell technically.
- MRTX stock price is 40.72 and Mirati Therapeutics 200-day simple moving average is 62.05, creating a Sell signal.
MRTX Technical Analysis vs Fundamental Analysis
Sell
13
Mirati Therapeutics (MRTX)
is a Sell
Is Mirati Therapeutics a Buy or a Sell?
-
Mirati Therapeutics stock is rated a Sell
The current Mirati Therapeutics [MRTX] share price is $40.72. The Score for MRTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Mirati Therapeutics Stock Info
Market Cap:
2.36B
Price in USD:
40.72
Share Volume:
554.71K
Mirati Therapeutics 52-Week Range
52-Week High:
101.30
52-Week Low:
32.96
Sell
13
Mirati Therapeutics (MRTX)
is a Sell
Mirati Therapeutics Share Price Forecast
-
What is the Mirati Therapeutics stock price today?
The Mirati Therapeutics stock price is 40.72 USD today. -
Will MRTX stock go up or go down?
Mirati Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Mirati Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mirati Therapeutics is overvalued.
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 40.72 while MRTX 8-day exponential moving average is 41.57, which is a Sell signal.
- The stock price of MRTX is 40.72 while Mirati Therapeutics 20-day EMA is 43.04, which makes it a Sell.
- Mirati Therapeutics 50-day exponential moving average is 46.55 while MRTX share price is 40.72, making it a Sell technically.
- MRTX stock price is 40.72 and Mirati Therapeutics 200-day simple moving average is 63.60, creating a Sell signal.
Fundamental Analysis of Mirati Therapeutics
Is Mirati Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $2.26 per share.
Technical Analysis of Mirati Therapeutics
Should I short Mirati Therapeutics stock?
- MRTX Moving Average Covergence Divergence (MACD) indicator is -1.73, suggesting Mirati Therapeutics is a Sell
- Mirati Therapeutics Relative Strength Index (RSI) is 39.46, which suggest Mirati Therapeutics is oversold
- The Bollinger Bands (25) for Mirati Therapeutics is (41.06 - 46.7), which suggest Mirati Therapeutics is a Sell
- The Bollinger Bands (100) for Mirati Therapeutics is (38.55 - 69.69), which suggest Mirati Therapeutics is a Sell
* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.